Structured Product Labeling (SPL)
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Defense Health Agency (DHA) Research and Development (R&D) – Medical Research and Development Command (MRDC) has issued an Unrestricted Combined Synopsis/Solicitation (HT942626QE022) for Structured Product Labeling (SPL) Generation services. This Firm Fixed-Price (FFP) contract aims to manage, process, and complete initial labeling and labeling changes for electronic SPL document submissions to the FDA. Proposals are due June 05, 2026, at 02:00 PM ET.
Purpose and Scope
The DHA R&D – MRDC requires support for its Office of Regulated Activities (ORA) to handle SPL submissions for its two licensed New Drug Application (NDA) products. The scope includes:
- Creating, updating, and submitting new and existing labels to the FDA for approval.
- Ensuring adherence to the latest FDA technical conformance criteria for SPL documents, including XML format and compliance regulations.
- Utilizing FDA-compliant validation software (e.g., Reed Tech, Pragmatic).
- Managing sensitive product data in a secure environment.
- Establishing and maintaining documented procedures for quality consistency, regulatory submissions, and records management.
- Providing optional surge support for increased SPL service requirements.
Contract Details
- Solicitation Number: HT942626QE022
- Contract Type: Firm Fixed Price (FFP)
- Set-Aside: Unrestricted
- NAICS Code: 541690 (Other Management Consulting Services)
- Size Standard: $19,000,000.00
- Period of Performance: A base year (June 30, 2026 - June 29, 2027) and four one-year option periods.
- Place of Performance: Services are for the ORA/DHA R&D/MRDC, located in Frederick, MD.
Submission and Evaluation
- Offer Due Date: June 05, 2026, 02:00 PM ET
- Questions Due: May 26, 2026, 02:00 PM ET
- Submission Requirements: Quotes must be submitted in three volumes: Technical Capability, Past Performance, and Price & Administrative.
- Evaluation Factors: Award will be made on a best-value tradeoff basis, considering Technical Capability, Past Performance, and Price.
Key Bidder Requirements
Bidders must address several critical attachments:
- Past Performance References (Attachment 3): Complete this form detailing relevant past contracts.
- Organizational Conflict of Interest (OCI) Certification Form (Attachment 2): Certify OCI status, as this requirement falls under OCI Category 3 (Product Support).
- Non-Disclosure Agreement (NDA) (Attachment 1): Ensure all personnel involved sign this agreement.
- Pricing Sheet (Attachment 4): Use this sheet to provide proposed costs for FFP CLINs across the base and option periods.